$14.92 -0.09 (%) Avanir Pharmaceuticals Inc - NASDAQ

Nov. 28, 2014 | 01:00 PM

Partner Headlines

  1. Micro-Cap ETF And The Falling Greenback

    Benzinga | Oct. 13, 2014 | 17:28PM EST
  2. Morning Market Movers

    Benzinga | Sep. 24, 2014 | 09:40AM EST
  3. Dow Down 0.6%; CarMax Shares Fall After Q2 Results

    Benzinga | Sep. 23, 2014 | 15:13PM EST
  4. Ascena Retail Drops On Downbeat Earnings; CF Industries Shares Gain

    Benzinga | Sep. 23, 2014 | 12:43PM EST
  5. Markets Mixed; Carnival Profit Tops Street View

    Benzinga | Sep. 23, 2014 | 11:20AM EST
  6. Morning Market Losers

    Benzinga | Sep. 23, 2014 | 09:47AM EST
  7. Morning Market Losers

    Benzinga | Sep. 16, 2014 | 09:49AM EST
  8. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 16, 2014 | 08:11AM EST
  9. Avanir Pharmaceuticals

    IBD | Sep. 15, 2014 | 18:53PM EST
  10. Technology Stocks Down As Rest Of The Market Starts Week Flat

    Benzinga | Sep. 15, 2014 | 17:15PM EST
  11. Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge

    Benzinga | Sep. 15, 2014 | 15:40PM EST
  12. NASDAQ Tumbles 1.1%; Alere Shares Surge Following Proposed $46/Share Offer

    Benzinga | Sep. 15, 2014 | 13:24PM EST
  13. Midday Gainers From September 15 - RadioShack Corporation, Rewalk Robotics Ltd And More

    Benzinga | Sep. 15, 2014 | 12:32PM EST
  14. Markets Fall; Cognizant To Acquire TriZetto For $2.7 Billion

    Benzinga | Sep. 15, 2014 | 11:26AM EST
  15. Benzinga's Volume Movers

    Benzinga | Sep. 15, 2014 | 10:17AM EST
  16. Morning Market Movers

    Benzinga | Sep. 15, 2014 | 09:42AM EST
  17. Avanir Pharmaceuticals Announces Positive Phase II Trial Results For AVP-923 In Treatment Of Agitation In Patients With Alzheimer's Disease

    Benzinga | Sep. 15, 2014 | 08:33AM EST
  18. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 11, 2014 | 10:06AM EST
  19. Events for the Week of Sept. 8-12

    Benzinga | Sep. 10, 2014 | 14:34PM EST
  20. U.S. Stocks Rise; Palo Alto Networks Shares Surge On Upbeat Revenue

    Benzinga | Sep. 10, 2014 | 12:48PM EST
  21. Avanir Pharmaceuticals Announces Initiation Of Phase II Study of AVP-786 For The Adjunctive Treatment Of Major Depressive Disorder

    Benzinga | Aug. 26, 2014 | 09:02AM EST
  22. Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of Major Depressive Disorder

    Benzinga | Jul. 21, 2014 | 09:17AM EST
  23. AVANIR Pharma Offers Three Presentations for AVP-825 for Acute Treatment of Migraine

    Benzinga | Jun. 24, 2014 | 08:32AM EST
  24. Morning Market Movers

    Benzinga | Jun. 10, 2014 | 09:39AM EST
  25. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 10, 2014 | 08:04AM EST
  26. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 2, 2014 | 08:30AM EST
  27. Avanir Pharmaceuticals Announces Data Presentation of Central Nervous System (CNS) Therapeutics Franchise at American Academy of Neurology Meeting

    Benzinga | Apr. 28, 2014 | 08:34AM EST
  28. Morning Market Movers

    Benzinga | Mar. 26, 2014 | 09:44AM EST
  29. UPDATE: Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine

    Benzinga | Mar. 26, 2014 | 09:01AM EST
  30. Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors

    Benzinga | Mar. 19, 2014 | 16:00PM EST
  31. Avanir Pharmaceuticals Announces Submission of New Drug Application for AVP-825 for the Acute Treatment of Migraine

    Benzinga | Jan. 30, 2014 | 09:01AM EST
  32. Mid-Afternoon Market Update: Markets Falling as Smith & Wesson Continues to Rise on Earnings

    Benzinga | Dec. 11, 2013 | 16:02PM EST
  33. Mid-Day Market Update: Smith & Wesson Gains On Upbeat Profit; LabCorp Shares Decline

    Benzinga | Dec. 11, 2013 | 12:29PM EST
  34. Mid-Morning Market Update: Markets Fall; Joy Global Profit Misses Estimates

    Benzinga | Dec. 11, 2013 | 11:37AM EST
  35. Morning Market Losers

    Benzinga | Dec. 11, 2013 | 10:05AM EST
  36. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 11, 2013 | 08:34AM EST
  37. Benzinga's Top Downgrades

    Benzinga | Dec. 11, 2013 | 08:13AM EST
  38. Earnings Scheduled For December 10, 2013

    Benzinga | Dec. 10, 2013 | 05:14AM EST
  39. Earnings Expectations For The Week Of December 9

    Benzinga | Dec. 8, 2013 | 20:09PM EST
  40. Avanir Pharma Reports Enrollment of First Patient in Study of AVP-923

    Benzinga | Oct. 22, 2013 | 08:36AM EST
  41. Mid-Afternoon Market Update: Apple Plummets Downwards As Markets Remain Mixed

    Benzinga | Sep. 16, 2013 | 16:01PM EST
  42. Mid-Day Market Update: Dow Jumps More Than 1%; Apple Shares Drop

    Benzinga | Sep. 16, 2013 | 12:43PM EST
  43. Mid-Morning Market Update: Markets Surge; Packaging Corp To Acquire Boise For $1.28B

    Benzinga | Sep. 16, 2013 | 11:01AM EST
  44. Benzinga's Top Pre-Market Gainers

    Benzinga | Sep. 16, 2013 | 08:15AM EST
  45. Market Wrap For Friday, September 13: Markets Erase August Losses On Light Volume

    Benzinga | Sep. 13, 2013 | 16:28PM EST
  46. Mid-Afternoon Market Update: Markets Green as Avanir Plummets

    Benzinga | Sep. 13, 2013 | 15:59PM EST
  47. Benzinga's Top Pre-Market Losers

    Benzinga | Sep. 13, 2013 | 09:47AM EST
  48. Avanir Shares Rebound As Analysts Offer Defense On Heels of 13% Drop

    Benzinga | Sep. 12, 2013 | 16:26PM EST
  49. Wedbush Reiterates Outperform on Avanir Pharmaceuticals on Buying Opportunity Created by Short Report

    Benzinga | Sep. 12, 2013 | 11:09AM EST
  50. Investors In Avanir Cheer As Piper Jaffray Lifts Target On Stock Sharply From $6 To $13

    Benzinga | Aug. 26, 2013 | 13:00PM EST
Trading Center